Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanaria PfSPZ Challenge with Pyrimethamine Chemoprophylaxis
NCT03083847Phase 1Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2017
- Primary completion
- Jun 2019
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of PfSPZ Challenge in malaria, sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoints: Number of Participants With P.Falciparum Blood Stage Infection, Number of Participants Requiring Treatment With Additional Anti-malarial Medication and 2 more. Started Jun 2017; status: completed.
02
Drugs
PfSPZ Challenge
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03083847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03083847.